Zevia PBC

NYSE:ZVIA

Beverages - Non-Alcoholic

Consumer Defensive
$0.97 +6.98%

+$0.09 today

Market cap
$70.03M
Beta
1.01
P/E (TTM)
-13.4
EPS (TTM)
-$0.10
52W Low $1.11High $3.66

Volume 0.26M

Average 0.89M

ZVIA Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Zevia PBCNYSE: ZVIA

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development remains negative

Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMMar 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How ZVIA compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Research & development amounts to 0.0% of revenue for ZVIA, versus a peer median of 0.5%.
ZVIA Competitors
Research & Development for ZVIA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SKILSkillsoft Corp.LTM Apr 2026$54.58M USD-8.0%-7.3%11.3%
YOULYoulife Group Inc.FY2025CN¥16.87M CNY+68.4%+0.3%0.9%
SKINThe Beauty Health CompanyLTM Mar 2026$5.73M USD+27.7%-12.6%1.9%
ZVIAZevia PBCLTM Mar 2026$0 USD——0.0%
ACUAcme United CorporationLTM Mar 2026$0 USD——0.0%
HFFGHF Foods Group Inc.LTM Mar 2026$0 USD——0.0%
FTLFFitLife Brands, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding ZVIA) —+27.7%-7.3%0.5%

Competitors are the stored peer set for ZVIA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue138.17M163.18M166.42M155.05M161.26M
Cost of Revenue74.23M93.16M91.67M83.12M84.71M
Gross Profit63.94M70.02M74.76M71.93M76.55M
Gross Margin46.3%42.9%44.9%46.4%47.5%
Research & Development00000
Selling, General & Admin150.37M116.54M102.09M92.12M82.41M
Operating Expenses151.37M117.89M103.7M95.58M86.17M
Depreciation & Amortization997K1.35M1.62M1.33M868K
EBITDA(86.64M)(46.24M)(26.66M)(20.19M)(10.24M)
EBITDA Margin-62.7%-28.3%-16.0%-13.0%-6.4%
Operating Income(87.43M)(47.87M)(28.94M)(23.65M)(9.62M)
Operating Margin-63.3%-29.3%-17.4%-15.3%-6.0%
Interest Income00000
Interest Expense00000
Other Income / Expenses(207K)286K673K(63K)(1.49M)
Income Before Tax(87.63M)(47.58M)(28.27M)(23.72M)(11.11M)
Pre-Tax Margin-63.4%-29.2%-17.0%-15.3%-6.9%
Income Tax Expense34K65K52K66K54K
Net Income(47.9M)(33.86M)(21.49M)(20.01M)(10.08M)
Net Margin-34.7%-20.7%-12.9%-12.9%-6.3%
EPS (Basic)(2.54)(1.10)(0.41)(0.34)(0.15)
EPS (Diluted)(2.54)(1.10)(0.41)(0.34)(0.15)
Weighted Avg Shares34.46M43.47M50.62M58.68M66.02M
Weighted Avg Shares (Diluted)34.46M43.47M50.62M58.68M66.02M

Zevia PBC

NYSE:ZVIA

Intrinsic Alpha fair value

Locked

Current Price

$0.97

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.